72795
document
Effects of propofol and isoflurane on haemodynamics and the inflammatory response in cardiopulmonary bypass surgery . Cardiopulmonary bypass ( CPB ) causes reperfusion injury that when most severe is clinically manifested as a systemic inflammatory response syndrome . The anaesthetic propofol may have anti-inflammatory properties that may reduce such a response . We hypothesised differing effects of propofol and isoflurane on inflammatory markers in patients having CBR Forty patients undergoing elective CPB were randomised to receive either propofol or isoflurane for maintenance of anaesthesia . CRP , IL-6 , IL-8 , HIF-1α ( ELISA ) , CD11 and CD18 expression ( flow cytometry ) , and haemoxygenase ( HO-1 ) promoter polymorphisms ( PCR/electrophoresis ) were measured before anaesthetic induction , 4 hours post-CPB , and 24 hours later . There were no differences in the 4 hours changes in CRP , IL-6 , IL-8 or CD18 between the two groups , but those in the propofol group had higher HIF-1α ( P = 0.016 ) and lower CD11 expression ( P = 0.026 ) . After 24 hours , compared to the isoflurane group , the propofol group had significantly lower levels of CRP ( P < 0.001 ) , IL-6 ( P < 0.001 ) and IL-8 ( P < 0.001 ) , with higher levels CD11 ( P = 0.009 ) and CD18 ( P = 0.002 ) expression . After 24 hours , patients on propofol had increased expression of shorter HO-1 GT ( n ) repeats than patients on isoflurane ( P = 0.001 ) . Use of propofol in CPB is associated with a less adverse inflammatory profile than is isofluorane , and an increased up-regulation of HO-1 . This supports the hypothesis that propofol has anti-inflammatory activity .
72796
Intervention_Pharmacological
propofol
72797
Intervention_Pharmacological
isoflurane
72798
Outcome_Physical
haemodynamics and the inflammatory response
72799
Outcome_Physical
inflammatory markers
72800
Outcome_Physical
CRP
72801
Outcome_Physical
IL-6 , IL-8
72802
Outcome_Physical
HIF-1α ( ELISA )
72803
Outcome_Physical
CD11
72804
Outcome_Physical
CD18
72805
Outcome_Physical
haemoxygenase ( HO-1
72806
Outcome_Physical
promoter polymorphisms ( PCR/electrophoresis )
72807
Outcome_Physical
CRP
72808
Outcome_Physical
IL-6
72809
Outcome_Physical
IL-8
72810
Outcome_Physical
CD18
72811
Outcome_Physical
higher HIF-1α
72812
Outcome_Physical
CD11 expression
72813
Outcome_Physical
CRP
72814
Outcome_Physical
IL-6
72815
Outcome_Physical
IL-8
72816
Outcome_Physical
levels CD11
72817
Outcome_Physical
CD18
72818
Outcome_Physical
HO-1 GT ( n
72819
Outcome_Physical
of HO-1
72820
Participant_Condition
Cardiopulmonary bypass ( CPB )
72821
Participant_Sample-size
Forty patients